TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03687983

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GoldenFlow Peripheral Stent System
Description: Performing anaesthetic and pathological angiography according to the standard method, and select appropriate stent specifications according to the contrast results. After 1:1 pre-expansion, the stent system will be imparted into the lesion location, the stent will be distally positioned and released. The Tip head will be reset and the conveyor will be removed. If necessary, local re-expansion can be carried out. Remove the catheter and suture the wound. Postoperative treatment and anticoagulation.
Study: NCT02723188

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation (1.5 milliampere,30 seconds)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DC stimulation (1.5 milliampere, 20 minutes)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AC stimulation (1.5 milliampere,1.5 Hertz frequency)
Study: NCT02182310

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 low dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 placebo

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: BI 201335 placebo

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 high dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 201335 high dose
Study: NCT03925142

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controlled healthy vegetarian diet
Description: The controlled healthy vegetarian diet will follow the Dietary Guidelines for American's recommendations. All foods and beverages will be provided during intervention to achieve the desired eating pattern.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Controlled beef diet
Description: The controlled beef diet will incorporate various cuts of lean unprocessed red meat into the healthy vegetarian eating pattern, as approved by the American Heart Association's Food Certification Program. The beef diet will isocalorically replace starchy vegetables and/or refined grains with 6 oz. of beef/day for five weeks.
Study: NCT04938076

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial direct current stimulation on motor cortex

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham control
Description: sham control
Study: NCT03937115

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 2 active tDCS sessions (20 min each, 2 mA) applied to the dlPFC and right motor cortex

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 2 active tDCS sessions (20 min each, 2 mA) applied to the dlPFC and right motor cortex

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 1 sham tDCS session (20 min, 0 mA) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 1 sham tDCS session (20 min, 0 mA) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 20 mA, 20 min each) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 20 mA, 20 min each) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 20 mA, 20 min each) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 0 mA, 20 min each) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 0 mA, 20 min each) applied to the dlPFC

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: 10 tDCS sessions (2 sessions/day for 5 days, 0 mA, 20 min each) applied to the dlPFC
Study: NCT04265521

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biocool Footcare
Description: BioCool Footcare is a footbath containing granulate of sodium percarbonate that will in this study be used for treatment of foot fungus, heel cracks, calluses and/or dry feet.
Study: NCT00732927

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: parnaparin
Description: vials, 6.400 IU sc twice daily for 7 days, then once daily for a total of 3 months

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aspirin
Description: tablets, 100 mg for 3 months
Study: NCT04545801

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.25 mg/kg of Ketamine
Description: patients will recieve 0.25mg/kg of ketamine intravenously 5 min after spinal anesthesia

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 20ml of normal saline solution
Description: 20ml of normal saline solution intravenously 5 minutes after spinal anesthesia
Study: NCT00036764

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ixabepilone
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacogenomic studies
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT02534168

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skin conductance monitor for measuring skin conductance
Description: The Skin conductance monitor for measuring skin conductance on the palm of the hand or sole of the foot in microSiemens (µS); it then calculates the number of skin conductance responses per second and the area under the registration curve.~The device records sympathetic autonomous nervous system through its effect on skin.~The device (Med-Storm Innovation AS, Gimle Terrasse 4, NO-0264 Oslo, Norway, support@med-storm.com) includes cables, skin electrodes, a measurement unit and a monitor.
Study: NCT04669431

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Xbox kinect Training
Description: Xbox kinect 360, Tennis player, Joy riding, Rally ball. Tennis player in first 2 weeks, Joy riding in 3rd and 4th weeks, and all 3 games in 5th and 6th weeks 35 minute/3 days a week for 6 weeks with Conventional physical therapy, 25 minute

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conservative Rehabilitation
Description: Sustained Stretching, repetitive task training, activities of daily living( eating, grooming, folding of towel, basket lifting, turn key into lock, reaching forward, sideways reach, ball grasping, picking up small blocks and lifting cane and pencil) 35 minute/3 days a week for 6 weeks
Study: NCT00962312

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lapatinib ditosylate
Study: NCT01484951

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brinzolamide 1% and timolol 0.5% fixed combination eye drops
Study: NCT02224625

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% CHG Cloth solution
Description: Investigational CHG

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Cloth
Description: Excipients from CHG cloth only

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator
Description: Active comparator

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Saline
Description: Negative control

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: SLS
Description: Provides a slight irritation for a positive control
Study: NCT01980433

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Repetitive Transcranial Magnetic Stimulation (rTMS)
Description: Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pre and post-rTMS electroencephalogram
Description: to verify the absence of infraclinical seizures

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: pre and post-rTMS electroencephalogram
Description: to verify the absence of infraclinical seizures

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WCRS
Description: Writer's cramp rating scale

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: WCRS
Description: Writer's cramp rating scale

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: handwriting scale DPRE
Description: handwriting in development and being evaluated by the NRC Wilson

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: handwriting scale DPRE
Description: handwriting in development and being evaluated by the NRC Wilson

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visual analog scale of discomfort writing and parameters collected on touchpad

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: visual analog scale of discomfort writing and parameters collected on touchpad
Study: NCT03278821

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self Match
Description: Video presentation of treatment option are shown to the patient whereafter the patient must choose between the five possible treatment options.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Expert Match
Description: Referral as usual to one of five possible treatment options. The referral is based on baseline data from the patient and by the means of an algorithm, used in daily clinical praxis.
Study: NCT03593200

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegcetacoplan
Description: Complement (C3) Inhibitor
Study: NCT04271124

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise training
Description: The patients are allocated to PR+ET group or PR Each group receive an exercise training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise training
Description: The patients are allocated to PR+ET group or PR Each group receive an exercise training
Study: NCT01328639

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TeamCare Depression Intervention
Description: The TeamCare-PCN intervention involves a registered nurse Care Manager (CM), who coordinates collaborative team management for patients with diabetes and depression. The goal of the intervention is to reduce depressive symptoms, achieve targets for cardio-metabolic measures and improve lifestyle behaviours. The intervention includes three phases: (1) managing depression and improving depressive symptoms, (2) managing diabetes and controlling blood glucose, blood pressure and cholesterol, and (3) improving lifestyle behaviours such as healthy eating, physical activity and smoking cessation.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual diabetes and depression care
Description: Usual care of diabetes and depression involves providing care by the family physician based on usual standards of care and available clinical practice guidelines. Usual care does not involve additional active support from the Care Manager.
Study: NCT03709251

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Walking
Description: Intense walking activity at an intensity of 70-80% of the maximum heart rate

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Casual Speed Walking
Description: Moderate intensity (50-60% of Heart Rate maximum)
Study: NCT00831116

Intervention type: DEVICE
Intervention: Intravascular Near Infrared Spectroscopy
Description: Intravascular imaging with a catheter based spectroscopy system.
Study: NCT01621386

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast
Description: Administered orally as a single daily 10 mg dose for 2 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: Administered orally as a single daily 20 mg dose for 2 weeks
Study: NCT03008811

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary vein isolation with cryoballoon catheter.
Description: Device: Arctic Front Advance™ cardiac cryoablation catheter system.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary vein isolation with radiofrequency ablation.
Description: Device: TactiCath™ Quartz irrigated ablation catheter (St. Jude Medical) with aid of 3-D mapping system (EnSite Precision, St. Jude Medical).
Study: NCT00835900

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: varenicline
Description: variable dosing schedule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT01892540

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: positron emission tomography/computed tomography
Description: Undergo PET/CT

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: positron emission tomography/computed tomography
Description: Undergo PET/CT

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: positron emission tomography/computed tomography
Description: Undergo PET/CT

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MRI
Description: Undergo PET/MRI positron emission tomography/magnetic resonance imaging hybrid imaging

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MRI
Description: Undergo PET/MRI positron emission tomography/magnetic resonance imaging hybrid imaging

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PET/MRI
Description: Undergo PET/MRI positron emission tomography/magnetic resonance imaging hybrid imaging

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Position Device

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Position Device
Study: NCT05148910

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Silver and copper IUD (TCu380Ag)
Description: An intrauterine device containing 380mm² of copper with a silver core.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Copper IUD (TCu380A)
Description: An intrauterine device containing 380mm² of copper.
Study: NCT02538952

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Xpert device
Description: Interventions in the Experimental phase of this stepped-wedge trial include: (a) ensuring WHO-recommended TB screening adopted, (b) situating trained TB case finding nurses in the clinics, (c) training clinic personnel in the TB diagnostic algorithms, and (d) activation of the Xpert diagnostic device.
Study: NCT05868317

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy With FOLFIRINOX ( 5 Fluorouracil, Oxaliplatine and Irinotecan)
Description: Induction chemotherapy with six cycles of modified 5 fluorouracil,oxaliplatin and irinotecan followed by short course radiotherapy (RT) (5x5 Gy), then two cycles of 5 fluorouracil and oxaliplatin based chemotherapy and surgery will be performed 6 to 8 weeks after completion of RT.~After surgery , continuation of chemotherapy with 4 cycles of 5 fluorouracil and oxaliplatin regardless of pathological response

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: Short Course Radiotherapy
Study: NCT03070795

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: early feeding
Description: start oral sips four hours after cesarean section

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: delayed feeding
Description: start oral feeding on post operation day 1 (\>12hours) after surgery
Study: NCT00346749

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone Propionate/Salmeterol Combination Product
Study: NCT00933725

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TCM intervention
Description: Drug: Particle of compound Chinese herbs(produced by San_jiu Medical \& Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China), mixing with boiled water, free of decoction, taken orally, twice a day, for two months.~One tablet placebo of Tibolone (provided by San_jiu Medical \& Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China, once every two days, taken orally, for two months.~Behavioral: TCM emotion treatment: made under the guide of TCM theory, administered by qualified TCM physician, for three times in two months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Western intervention
Description: Drug: Tibolone, (produced by Oujianong corporation, Nanjing, China), 2.5mg, once every two days, taken orally, for two months; Particle placebo of compound Chinese herbs (produced by San_jiu Medical \& Pharmaceutical Limited Company, Guangzhou, Guangdong Province, China), mixing with boiled water, free of decoction, taken orally, twice a day, for two months.~Behavioral: supportive psychotherapy, administered by qualified physician, for three times in two months.
Study: NCT03359434

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clearsight device (Edwards) around the finger
Description: Continuous measurement of blood pressure with the Clearsight device (Edwards) around the finger, within 24 hours after reperfusion:

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent blood pressure measurements with cuff.
Description: Standard method: 35 blood pressure measurements with cuff within 24 hours after reperfusion
Study: NCT00652847

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ezetimibe
Description: ezetimibe 10 mg/day for a six week course of treatment.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: statins
Description: patients on statins have their dose doubled for 6 weeks followed by another 6 month observational phase

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: statins
Description: patients on statins have their dose doubled for 6 weeks followed by another 6 month observational phase
Study: NCT04135404

Intervention type: OTHER
Intervention: health-related telephone surveys
Description: The Behavioral Risk Factor Surveillance System (BRFSS) is a health-related telephone surveys that collect state data about United States residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services (Secondary-data analysis).
Study: NCT02538952

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intensified TB Case Finding (ICF)
Description: Interventions in the active comparator phase of this stepped wedge trial only include: (a) adoption of the WHO-recommended 4-symptom TB screen for adults; (b) situating trained TB case-finding nurses in the 22 facilities; and (c) training health facility personnel in TB diagnostic algorithms. There is no Xpert device activation in this phase. Only the standard of care microscopy algorithm (smear microscopy and chest x-ray) are available during this phase.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensified TB Case Finding (ICF)
Description: Interventions in the active comparator phase of this stepped wedge trial only include: (a) adoption of the WHO-recommended 4-symptom TB screen for adults; (b) situating trained TB case-finding nurses in the 22 facilities; and (c) training health facility personnel in TB diagnostic algorithms. There is no Xpert device activation in this phase. Only the standard of care microscopy algorithm (smear microscopy and chest x-ray) are available during this phase.
Study: NCT02667340

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Superstarch
Description: 0.7 g Superstarch or placebo per kg body mass in two ingestions (before game \& at halftime)

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.7 g glucose per kg body mass in two ingestions (before game \& at halftime)
Study: NCT04993573

Intervention type: OTHER
Intervention: Questionnaire
Description: Questions about the impact of COVID-19 in their works

Intervention type: OTHER
Intervention: Individual interview
Description: Discussion between the searcher and the participant about representations of COVID-19 and experiences about confinement.
Study: NCT00913081

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin
Description: Quercetin 500, 1000, or 2000 mg PO one time

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin
Description: Quercetin 500, 1000, or 2000 mg PO one time

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Quercetin
Description: Quercetin 500, 1000, or 2000 mg PO one time

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo PO one time
Study: NCT02806713

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenazopyridine

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: no Phenazopyridine
Description: Because the obvious effects on the urine coloration of pyridium no placebo or dummy are provided
Study: NCT03632564

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: REVIVIEW dichoptic audio-visual stimulation
Description: REVIVIEW dichoptic audio-visual stimulation using video goggles
Study: NCT02012400

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: The exercise group is given a 24-week individualized training program, including aerobic exercise, muscular training, relaxation exercises and stretching. Patients are asked to observe their asthma control daily and to mark in their diary asthma symptoms and activity limitations as well as duration, intensity and form of exercising on daily basis. They are also asked to perform PEF-measurements twice a day for one-week period every 4 weeks. The control group receives ordinary instructions.
Study: NCT00194129

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lithium
Description: Lithium monotherapy was initiated at 300 mg twice daily and titrated over 3-6 weeks to minimum blood levels of 0.8 meq/L.
Study: NCT03140839

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Imaginal Rescripting
Description: A stand-alone single session intervention for social anxiety disorder

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Imaginal Exposure
Description: A stand-alone single session intervention for social anxiety disorder

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Supportive Counselling
Description: Non-specific talk therapy focused on non-directive and empathic listening and on supporting patients' existing coping skills and strategies.
Study: NCT03974477

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SALT CONTROL H equipment to control and monitor salt during cooking process
Description: Participants will use SALT CONTROL H at home during 8 weeks to cook meals with adequate salt content.